20 April 2025

Last updated: Wednesday 16 April 2025

Drug discovery

Will gene editing unmask synthetic lethal targets?

The need for innovation in neuroscience

Meeting Report: Funding rises for early assets

The productivity of oncology development continues

Exscientia raises $26 million, partners with Roche

IMI: Building a science infrastructure for Europe

A strategy for using AI in pharma R&D

Light on the horizon for Swedish biopharma

Galecto raises €79 million in Series C round

RNA therapeutics are now a clinical reality